Jade Biosciences (JBIO) had its price target raised by BTIG Research from $28.00 to $39.00. They now have a "buy" rating on the stock.
Jade Biosciences (JBIO) was downgraded by Zacks Research from "hold" to "strong sell".
Jade Biosciences (JBIO) had its price target raised by Guggenheim from $17.00 to $23.00. They now have a "buy" rating on the stock.
Jade Biosciences (JBIO) was upgraded by William Blair to "strong-buy".
Jade Biosciences (JBIO) had its "outperform" rating reaffirmed by Wedbush. They now have a $24.00 price target on the stock.